SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-021369
Filing Date
2022-08-04
Accepted
2022-08-04 17:29:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 13793
2 proxy_001.jpg GRAPHIC 231602
3 proxy_002.jpg GRAPHIC 166053
  Complete submission text file 0001493152-22-021369.txt   562545
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40652 | Film No.: 221137879
SIC: 2834 Pharmaceutical Preparations